Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Treatment Discontinuation by 3 Years After Levothyroxine Initiation among Children Diagnosed with Congenital Hypothyroidism
  • Published Date:
    May 11 2020
  • Source:
    J Pediatr. 223:136-140
  • Language:
    English


Public Access Version Available on: August 01, 2021, 12:00 AM information icon
Please check back on the date listed above.
Details:
  • Alternative Title:
    J Pediatr
  • Description:
    Background: Newborn screening identifies infants with congenital hypothyroidism (CH) for whom levothyroxine (L-T4) prevents cognitive impairment but also can identify infants with transient hypothyroidism. For some, transient hypothyroidism can be ruled out by thyroid gland imaging; otherwise, it is confirmed when thyroid stimulating hormone (TSH) concentrations remain normal after a supervised trial off L-T4, typically after age 3 years. Objectives: To measure the rates of thyroid gland imaging and L-T4 discontinuation and to assess whether discontinuation was monitored with TSH testing. Methods: This is a retrospective analysis of claims data from the IBM® MarketScan® Databases for children born during 2010–2016 and continuously enrolled in a non-capitated employer-sponsored private health insurance plan or in Medicaid for ≥36 months from the date of the first filled L-T4 prescription. Results: 263 privately-insured and 241 Medicaid-enrolled children met the inclusion criteria. More privately-insured than Medicaid-enrolled children had imaging between the first filled prescription and 180 days after the last filled prescription (24.3% vs. 12.9%; P=0.001). By 36 months, 35.7% discontinued L-T4, with no difference by insurance status (P=0.48). Among those who discontinued, 29.1% of privately-insured children and 47.7% of Medicaid-enrolled children had no claims for TSH testing within the next 180 days (P=0.01). Conclusions: Nearly one-third of children with suspected CH discontinued L-T4 by 3 years and fewer Medicaid-enrolled than privately-insured children received timely follow-up TSH testing. Future studies are indicated to understand the quality of care and developmental outcomes for children with CH and barriers to guideline adherence in evaluating for transient CH.
  • Subject:
  • Pubmed ID:
    32437757
  • Pubmed Central ID:
    PMC7427425
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: